Greenhouse gas emissions related to pharmaceutical consumption increased by 77% over the past 24 years, according to a Leiden ...

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 ...

BCCI Announces Massive Cash Reward for Team India’s ICC Champions Trophy Triumph 5 Vegan superfoods that are healthier and more protein-packed than eggs 5 smartphones under Rs 20,000 that stand ...

The Environmental Protection Agency on Wednesday said it would "formally reconsider" a landmark 2009 finding by the agency that greenhouse gases are a danger to public health. The announcement was ...

The Environmental Protection Agency will move to reverse its 2009 declaration that greenhouse gases endanger human health and welfare — a step that would threaten most major climate regulations ...

Equinor has already scaled back its target for installed renewable energy capacity to 10-12 gigawatts (GW) by 2030 ... describing the amount of greenhouse gases emitted per unit of activity.

A greenhouse is a major investment for your garden and one that’s not easy to move or replace once installed, so it's important to pick the right one for your needs. Whether you're shopping for a ...

However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some analysts project that Rezdiffra could generate peak annual sales of close to $3.5 ...

India, the world's third-biggest emitter of greenhouse gases, aims to add 500 gigawatts (GW) of renewable energy by 2030, up from 165 GW currently, while also aiming for net zero emissions by 2070.

India, the world's third-biggest emitter of greenhouse gases, aims to add 500 gigawatts (GW) of renewable energy by 2030, up from 165 GW currently, while also aiming for net zero emissions by 2070.

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...